Clinical trial
The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese…
NCT00222833 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00222833 |
|---|---|
| Title | The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia |
| Official title | The Effect of Switching to Aripiprazole on Indices of Cardiovascular Health in Overweight and Obese Patients With Schizophrenia |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Overweight, Hyperlipidemia, Cardiovascular Diseases |
| Intervention type | Drug |
| Interventions | Aripiprazole |
| Enrollment | 30 |
| Start date | Oct 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: